09:30–09:35 Welcome and introduction
09:35–09:50 What is the rationale for targeting CD30 in sALCL and cutaneous T-cell lymphoma?
Andreas Engert – Germany
09:50–10:05 What is the clinical evidence and what are the ongoing trials for CD30-targeting agents?
Timothy Illidge – UK
10:05–10:25 Case presentation:
How to optimize the management of sALCL patients in daily practice
Christian Gisselbrecht – France